LEO Pharma
LEO Pharma Inc.
1 Sylvan Way
Parsippany NJ 07054
Phone: (877) 494 4536Website: https://www.leo-pharma.us/Careers: www.leo-pharma.us/Home/Work-With-Us.aspx
Latest news
- LEO Pharma Inc. Announces U.S. FDA Approval of Adbry (tralokinumab-ldrm) for the Treatment of Moderate-to-Severe Atopic Dermatitis in Pediatric Patients Aged 12-17 Years
15 December 2023 - FDA Approves Adbry (tralokinumab-ldrm) for Adults with Moderate-to-Severe Atopic Dermatitis
28 December 2021 - LEO Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of Biologics License Application (BLA) for Tralokinumab for the Treatment of Adults with Moderate-to-Severe Atopic Dermatitis
9 July 2020 - Tralokinumab Achieves Primary and Secondary Endpoints in Three Pivotal Phase 3 Trials in Adult Patients with Moderate-to-Severe Atopic Dermatitis
12 June 2020 - LEO Pharma Announces U.S. Approval of Enstilar Foam (calcipotriene/betamethasone dipropionate) for Plaque Psoriasis
19 October 2015
Drugs Associated with LEO Pharma Inc.
LEO Pharma Inc. manufactures, markets and/or distributes more than 6 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Adbry
Generic name: tralokinumab Drug class: interleukin inhibitors |
3 reviews | 6.0 / 10 |
|
Dovonex
Generic name: calcipotriene Drug class: topical antipsoriatics |
23 reviews | 6.5 / 10 |
|
Enstilar
Generic name: betamethasone/calcipotriene Drug class: topical antipsoriatics |
67 reviews | 6.7 / 10 |
|
Picato
Generic name: ingenol Drug class: topical antineoplastics |
17 reviews | 5.5 / 10 |
|
Taclonex
Generic name: betamethasone/calcipotriene Drug class: topical antipsoriatics |
42 reviews | 7.9 / 10 |
|
Taclonex Scalp
Generic name: betamethasone/calcipotriene Drug class: topical antipsoriatics |
4 reviews | 8.8 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
